环孢素A（CyA）治疗原发性干燥综合征：一项双盲研究。
Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study.
作者信息
Drosos A A, Skopouli F N, Costopoulos J S, Papadimitriou C S, Moutsopoulos H M
出版信息
Ann Rheum Dis. 1986 Sep;45(9):732-5. doi: 10.1136/ard.45.9.732.
Abstract
The efficacy and toxicity of cyclosporin A (CyA) were studied in a blind fashion in 20 patients with primary Sjögren's syndrome (pSS). The dose of CyA or placebo was 5 mg/kg of body weight daily. Among the 20 patients, 10 received CyA and 10 placebo. The two groups were matched for age, sex, and disease duration. Patients treated with CyA improved in subjective xerostomia in comparison with patients treated with placebo. Subjective xerophthalmia and recurrent parotid gland enlargement did not differ in the two groups. No change in Schirmer's test and stimulated parotid flow rate was observed in either group. In contrast, the histopathological lesion of patients treated with CyA remained unchanged in most of the patients, while in the placebo treated group the lesion deteriorated. Laboratory parameters did not change before or after treatment in either group. The only clinical side effect observed in the CyA treated group was hypertrichosis.
摘要
以盲法研究了环孢素A（CyA）对20例原发性干燥综合征（pSS）患者的疗效和毒性。CyA或安慰剂的剂量为每日5mg/kg体重。20例患者中，10例接受CyA治疗，10例接受安慰剂治疗。两组在年龄、性别和病程方面相匹配。与接受安慰剂治疗的患者相比，接受CyA治疗的患者主观口干症状有所改善。两组患者的主观眼干和腮腺反复肿大情况无差异。两组患者的泪液分泌试验和刺激后的腮腺流速均未观察到变化。相比之下，接受CyA治疗的患者中大多数患者的组织病理学病变保持不变，而接受安慰剂治疗的组病变恶化。两组治疗前后实验室参数均未改变。CyA治疗组观察到的唯一临床副作用是多毛症。
相似文献
1
Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study.环孢素A（CyA）治疗原发性干燥综合征：一项双盲研究。
Ann Rheum Dis. 1986 Sep;45(9):732-5. doi: 10.1136/ard.45.9.732.
2
[Effectiveness and safety of using cyclosporin A in the treatment of primary Sjögren's syndrome].
Ter Arkh. 1988;60(4):77-80.
3
Cyclosporin a therapy in patients with primary Sjögren's syndrome: results at one year.环孢素A治疗原发性干燥综合征患者：一年的结果
Scand J Rheumatol Suppl. 1986;61:246-9.
4
Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjögren's syndrome.环孢素A（CyA）对干燥综合征患者唇小唾液腺免疫病理损伤的影响。
Ann Rheum Dis. 1987 Feb;46(2):89-92. doi: 10.1136/ard.46.2.89.
5
Sjögren's syndrome in systemic lupus erythematosus.系统性红斑狼疮中的干燥综合征。
J Rheumatol. 1990 Feb;17(2):201-4.
6
Nandrolone decanoate (deca-durabolin) in primary Sjögren's syndrome: a double blind pilot study.癸酸诺龙（长效多乐宝灵）治疗原发性干燥综合征：一项双盲试验性研究。
Clin Exp Rheumatol. 1988 Jan-Mar;6(1):53-7.
7
Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.原发性干燥综合征的个体化治疗：腮腺病理活检预测利妥昔单抗治疗反应。
Ann Rheum Dis. 2016 Nov;75(11):1933-1938. doi: 10.1136/annrheumdis-2015-208304. Epub 2016 Jan 12.
8
A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.一项针对干燥综合征患者口服α-干扰素含片疗效的试点研究。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jan;95(1):38-44. doi: 10.1067/moe.2003.30.
9
The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.白芍总苷治疗原发性干燥综合征的疗效和安全性：一项多中心、随机、双盲、安慰剂对照临床试验。
Clin Rheumatol. 2019 Mar;38(3):657-664. doi: 10.1007/s10067-018-4315-8. Epub 2018 Oct 2.
10
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome.一项口服塞来昔布在原发性干燥综合征中的 2 期随机、双盲、安慰剂对照、概念验证研究。
Rheumatology (Oxford). 2021 Mar 2;60(3):1364-1375. doi: 10.1093/rheumatology/keaa410.
引用本文的文献
1
Primary Sjögren's syndrome: new perspectives on salivary gland epithelial cells.原发性干燥综合征：唾液腺上皮细胞的新视角
Eur J Med Res. 2024 Jul 17;29(1):371. doi: 10.1186/s40001-024-01967-5.
2
A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes.对法国卫生高级管理局（Haute Autorité de Santé）和英国国家卫生与临床优化研究所（National Institute for Health and Care Excellence）针对Ikervis®用于治疗尽管使用泪液替代物治疗但仍未改善的成人干眼症严重角膜炎的卫生技术评估的比较综述。
J Mark Access Health Policy. 2017 Aug 3;5(1):1336043. doi: 10.1080/20016689.2017.1336043. eCollection 2017.
3
The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.环孢素A在风湿病学中的应用：2016年综合综述
Clin Rev Allergy Immunol. 2017 Jun;52(3):401-423. doi: 10.1007/s12016-016-8582-3.
4
A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndrome.一项由研究者发起的II期试验性研究，使用低剂量环孢素A治疗原发性干燥综合征的关节受累。
Clin Rheumatol. 2016 Sep;35(9):2203-10. doi: 10.1007/s10067-016-3360-4. Epub 2016 Jul 28.
5
Treatment of primary Sjögren syndrome.原发性干燥综合征的治疗。
Nat Rev Rheumatol. 2016 Aug;12(8):456-71. doi: 10.1038/nrrheum.2016.100. Epub 2016 Jul 14.
6
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome.EULAR 干燥综合征疾病活动指数：原发性干燥综合征共识系统性疾病活动指数的制定。
Ann Rheum Dis. 2010 Jun;69(6):1103-9. doi: 10.1136/ard.2009.110619. Epub 2009 Jun 28.
7
Conventional therapy of Sjogren's syndrome.干燥综合征的传统疗法。
Clin Rev Allergy Immunol. 2007 Jun;32(3):284-91. doi: 10.1007/s12016-007-8008-3.
8
[Sjögren's syndrome. Current aspects from a rheumatological point of view].[干燥综合征。从风湿病学角度看的当前状况]
Z Rheumatol. 2006 Oct;65(6):505-17; quiz 518-9. doi: 10.1007/s00393-006-0101-0.
9
Recent advances in the management of ocular complications of Sjögren's syndrome.干燥综合征眼部并发症管理的最新进展
Curr Allergy Asthma Rep. 2005 Jul;5(4):327-32. doi: 10.1007/s11882-005-0077-x.
10
Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye.环孢素的眼药代动力学及安全性，一种新型的干眼局部治疗药物。
Clin Pharmacokinet. 2005;44(3):247-61. doi: 10.2165/00003088-200544030-00003.
本文引用的文献
1
2
Cyclosporin A for the treatment of systemic lupus erythematosus.环孢素A治疗系统性红斑狼疮。
Int J Immunopharmacol. 1981;3(2):163-9. doi: 10.1016/0192-0561(81)90007-2.
3
Inhibition of T-cell activity by cyclosporin A.环孢菌素A对T细胞活性的抑制作用。
Scand J Immunol. 1981 May;15(5):449-58. doi: 10.1111/j.1365-3083.1982.tb00670.x.
4
Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents.环孢素A治疗对全身用皮质类固醇和细胞毒性药物耐药的眼内炎性疾病。
Am J Ophthalmol. 1983 Sep;96(3):275-82. doi: 10.1016/s0002-9394(14)77814-6.
5
Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment.环孢素治疗期间重度格雷夫斯眼病病情恶化。
Lancet. 1984 Nov 10;2(8411):1101. doi: 10.1016/s0140-6736(84)91541-1.
6
Cyclosporin improves Graves' ophthalmopathy.
Lancet. 1983 Aug 27;2(8348):486-9. doi: 10.1016/s0140-6736(83)90514-7.
7
Treatment of intraocular inflammatory disease with cyclosporin A.用环孢素A治疗眼内炎性疾病。
Lancet. 1983 Jul 30;2(8344):235-8. doi: 10.1016/s0140-6736(83)90230-1.
8
Xerostomia. Clinical aspects, pathology and pathogenesis.口干症。临床症状、病理学及发病机制。
Acta Odontol Scand. 1967;25:Suppl 49:1-126.
9
Minor salivary gland involvement in Sjögren's syndrome.干燥综合征中的小唾液腺受累情况。
Oral Surg Oral Med Oral Pathol. 1974 Jan;37(1):64-74. doi: 10.1016/0030-4220(74)90160-1.
10
Cyclosporin for rheumatoid arthritis: one case.环孢素治疗类风湿关节炎：1例报告
Clin Exp Rheumatol. 1985 Oct-Dec;3(4):361-2.
Zotero 插件